Literature DB >> 19640764

[Use of IGRT for prostate cancers (OBI-CBCT Varian, ExacTrac BrainLAB and MVCT TomoTherapy)].

G Delpon1, C Llagostera, M Le Blanc, E Rio, S Supiot, M-A Mahé, A Lisbona.   

Abstract

INTRODUCTION: The aim of this work was to report the experience of image-guided radiotherapy at the CLCC Nantes-Atlantique using three repositioning imaging devices, the ExacTrac (BrainLAB), the OBI-CBCT (Varian) and the MVCT (Tomotherapy Inc), in the case of prostate external radiotherapy.
MATERIAL AND METHODS: For each linac and its imaging device, a treatment plan was described. Moreover, studies concerning calculated shifts after imaging sessions were achieved. Using ExacTrac, for eight patients, a study compared daily shifts based on bony anatomy or on implanted markers. Considering mean values of displacements over a course of radiotherapy, dosimetric impact was evaluated. With the OBI-CBCT, two imaging modalities were used, kV-kV (0 degrees and 270 degrees ) and CBCT. Up to now, whatever the images, displacements were calculated using the bony anatomy. For both modalities and for 26 patients, shifts were compared. Since the beginning of the Tomotherapy HiArt use, MVCT was performed for each session of each patient. For 12 patients, mean displacements were calculated after five fractions. Then the deviations to those values were calculated. This was done to show the relevance of daily MVCT. RESULTS AND
CONCLUSION: This work allows us to report the use of three repositioning imaging devices in the radiotherapy department. At least they provide an efficient positioning tool. And they let us see the future radiotherapy which would probably be the dose-guided radiotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19640764     DOI: 10.1016/j.canrad.2009.06.001

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Significance of image guidance to clinical outcomes for localized prostate cancer.

Authors:  Qiuzi Zhong; Hong Gao; Gaofeng Li; Xia Xiu; Qinhong Wu; Ming Li; Yonggang Xu
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

2.  Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer.

Authors:  Aurore Goineau; Virginie Marchand; Jérome Rigaud; Sylvain Bourdin; Emmanuel Rio; Loic Campion; Angélique Bonnaud-Antignac; Marc-André Mahé; Stéphane Supiot
Journal:  Radiat Oncol       Date:  2013-03-06       Impact factor: 3.481

3.  Study of ExacTrac X-ray 6D IGRT setup uncertainty for marker-based prostate IMRT treatment.

Authors:  Chengyu Shi; Adam Tazi; Deborah Xiangdong Fang; Christopher Iannuzzi
Journal:  J Appl Clin Med Phys       Date:  2012-05-10       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.